These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 24993448

  • 1. Regional citrate anticoagulation for RRTs in critically ill patients with AKI.
    Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E.
    Clin J Am Soc Nephrol; 2014 Dec 05; 9(12):2173-88. PubMed ID: 24993448
    [Abstract] [Full Text] [Related]

  • 2. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW, Foringer JR.
    Ren Fail; 2005 Dec 05; 27(5):541-5. PubMed ID: 16152991
    [Abstract] [Full Text] [Related]

  • 3. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group.
    JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849
    [Abstract] [Full Text] [Related]

  • 4. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW.
    Am J Kidney Dis; 2012 Jun 27; 59(6):810-8. PubMed ID: 22226564
    [Abstract] [Full Text] [Related]

  • 5. Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D, Amman J, Kleinekofort W, Morgera S.
    Int J Artif Organs; 2008 Apr 27; 31(4):363-6. PubMed ID: 18432594
    [Abstract] [Full Text] [Related]

  • 6. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.
    Kutsogiannis DJ, Gibney RT, Stollery D, Gao J.
    Kidney Int; 2005 Jun 27; 67(6):2361-7. PubMed ID: 15882280
    [Abstract] [Full Text] [Related]

  • 7. Renal replacement therapy and anticoagulation.
    Brandenburger T, Dimski T, Slowinski T, Kindgen-Milles D.
    Best Pract Res Clin Anaesthesiol; 2017 Sep 27; 31(3):387-401. PubMed ID: 29248145
    [Abstract] [Full Text] [Related]

  • 8. Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.
    Fiaccadori E, Pistolesi V, Mariano F, Mancini E, Canepari G, Inguaggiato P, Pozzato M, Morabito S.
    J Nephrol; 2015 Apr 27; 28(2):151-64. PubMed ID: 25585821
    [Abstract] [Full Text] [Related]

  • 9. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S, Pistolesi V, Cibelli L, Pierucci A.
    G Ital Nefrol; 2009 Apr 27; 26(1):13-21. PubMed ID: 19255959
    [Abstract] [Full Text] [Related]

  • 10. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial.
    Meersch M, Küllmar M, Wempe C, Kindgen-Milles D, Kluge S, Slowinski T, Marx G, Gerss J, Zarbock A, SepNet Critical Care Trials Group.
    BMJ Open; 2019 Jan 21; 9(1):e024411. PubMed ID: 30670518
    [Abstract] [Full Text] [Related]

  • 11. [Anticoagulation for continuous renal replacement therapy in the intensive care unit: a comparison of dalteparin infusion with regional citrate anticoagulation].
    Uljas E, Karjalainen M, Vaara S, Reinikainen M.
    Duodecim; 2015 Jan 21; 131(11):1079-84. PubMed ID: 26245070
    [Abstract] [Full Text] [Related]

  • 12. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
    Arnold F, Westermann L, Rieg S, Neumann-Haefelin E, Biever PM, Walz G, Kalbhenn J, Tanriver Y.
    BMC Nephrol; 2020 Nov 16; 21(1):486. PubMed ID: 33198670
    [Abstract] [Full Text] [Related]

  • 13. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.
    Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS.
    Am J Kidney Dis; 1996 Apr 16; 27(4):519-24. PubMed ID: 8678062
    [Abstract] [Full Text] [Related]

  • 14. [Regional citrate anticoagulation for continuous haemodiafiltration in the postoperative period].
    Kucewicz E, Zegleń S, Wojarski J, Ochman M, Skuza K, Szczepańska A, Podwińska E, Pacholewicz J, Przybylski R.
    Anestezjol Intens Ter; 2009 Apr 16; 41(4):238-41. PubMed ID: 20201346
    [Abstract] [Full Text] [Related]

  • 15. [Choice and management of anticoagulation during CRRT].
    Ricci D, Panicali L, Cavallari G, Facchini MG, Mancini E.
    G Ital Nefrol; 2019 Apr 16; 36(2):. PubMed ID: 30983172
    [Abstract] [Full Text] [Related]

  • 16. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D.
    Ther Apher Dial; 2013 Apr 16; 17(2):202-12. PubMed ID: 23551677
    [Abstract] [Full Text] [Related]

  • 17. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
    Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, Peters H, Slowinski T.
    J Crit Care; 2014 Apr 16; 29(2):265-71. PubMed ID: 24360392
    [Abstract] [Full Text] [Related]

  • 18. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC.
    Nephrol Dial Transplant; 2011 Jan 16; 26(1):232-9. PubMed ID: 20876598
    [Abstract] [Full Text] [Related]

  • 19. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R, Niles JL.
    Kidney Int; 1999 May 16; 55(5):1991-7. PubMed ID: 10231464
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.
    Clark JA, Schulman G, Golper TA.
    Clin J Am Soc Nephrol; 2008 May 16; 3(3):736-42. PubMed ID: 18272829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.